======= TXLNG =======
== Gene Information ==
* **Official Symbol**: TXLNG
* **Official Name**: taxilin gamma
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55787|55787]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NUQ3|Q9NUQ3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TXLNG&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TXLNG|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/300677|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the taxilin family. The encoded protein binds to the C-terminal coiled-coil region of syntaxin family members 1A, 3A and 4A, and may play a role in intracellular vesicle trafficking. This gene is up-regulated by lipopolysaccharide and the gene product may be involved in cell cycle regulation. The related mouse protein was also shown to inhibit activating transcription factor 4-mediated transcription and thus regulate bone mass accrual. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009].
* **UniProt Summary**: May be involved in intracellular vesicle traffic. Inhibits ATF4-mediated transcription, possibly by dimerizing with ATF4 to form inactive dimers that cannot bind DNA. May be involved in regulating bone mass density through an ATF4-dependent pathway. May be involved in cell cycle progression. {ECO:0000269|PubMed:15911876, ECO:0000269|PubMed:18068885}.
|Taxilin|
|syntaxin binding|
|regulation of bone mineralization|
|regulation of biomineral tissue development|
|regulation of biomineralization|
|regulation of ossification|
|nuclear membrane|
|protein heterodimerization activity|
|regulation of cell cycle process|
|regulation of cell cycle|
|cell cycle|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp481|Ethambutol 25μM R08 exp481]]|-1.82|
|[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-1.81|
|[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|-1.77|
|[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.76|
|[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.73|
|[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|-1.72|
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.82|
|[[:results:exp144|PFI-3 10μM R03 exp144]]|2.01|
|[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|2.14|
|[[:results:exp516|Pyrazinamide 100μM R08 exp516]]|2.46|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/694
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/26|
|bone|0/26|
|breast|0/30|
|central nervous system|0/49|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/11|
|fibroblast|0/1|
|gastric|0/14|
|kidney|0/18|
|liver|0/19|
|lung|0/72|
|lymphocyte|0/16|
|ovary|0/25|
|pancreas|0/22|
|peripheral nervous system|0/15|
|plasma cell|0/12|
|prostate|0/1|
|skin|0/20|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/28|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 10014
* **Expression level (log2 read counts)**: 6.23
{{:chemogenomics:nalm6 dist.png?nolink |}}